Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Usage Information

Radioiodination of human intrinsic factor
Iain L. Mackenzie, … , Robert M. Donaldson Jr., Robert F. Schilling
Iain L. Mackenzie, … , Robert M. Donaldson Jr., Robert F. Schilling
Published March 1, 1969
Citation Information: J Clin Invest. 1969;48(3):516-524. https://doi.org/10.1172/JCI106009.
View: Text | PDF
Research Article

Radioiodination of human intrinsic factor

  • Text
  • PDF
Abstract

Human intrinsic factor (IF) saturated with 60Co-labeled cyanocobalamin (60CoB12) was purified and then iodinated with 125I to yield 125I-labeled IF-60CoB12 preparations of high specific activity. Sephadex G200 and DEAE-cellulose chromatography of the iodinated IF-60CoB12 complex showed coincidence of the major 125I and the 60Co radioactivity peaks. During starch-gel electrophoresis 60Co radioactivity from noniodinated and iodinated complexes migrated to the same extent while 125I radioactivity from the iodinated complex migrated slightly further anodally than did the 60Co radioactivity. After the iodinated complex was mixed with antibody to the IF-B12 complex (antibody II) the 125I and 60Co radioactivity were: (a) precipitated in similar amounts by antiglobulin serum. (b) eluted coincidentally in the 19S region on Sephadex G200, and (c) excluded to the same extent from starch gel during electrophoresis. After equilibrium exchange of IF “blocking” antibody (antibody I) for 60Co-vitamin B12 on 125I-labeled IF. 125I radioactivity from the IF-antibody I complex: (a) was precipitated by antiglobulin serum, (b) was eluated in the 19S region on Sephadex G200 gel filtration, and (c) migrated slowly towards the anode on starch-gel electrophoresis. Urinary excretion of 60Co radioactivity in pernicious anemia patients after oral administration of 60Co-vitamin B12 bound to freshly prepared 125I-labeled IF was similar to that obtained with noniodinated intrinsic factor.

Authors

Iain L. Mackenzie, Robert M. Donaldson Jr., Robert F. Schilling

×

Usage data is cumulative from May 2024 through May 2025.

Usage JCI PMC
Text version 85 0
PDF 34 7
Scanned page 359 1
Citation downloads 47 0
Totals 525 8
Total Views 533

Usage information is collected from two different sources: this site (JCI) and Pubmed Central (PMC). JCI information (compiled daily) shows human readership based on methods we employ to screen out robotic usage. PMC information (aggregated monthly) is also similarly screened of robotic usage.

Various methods are used to distinguish robotic usage. For example, Google automatically scans articles to add to its search index and identifies itself as robotic; other services might not clearly identify themselves as robotic, or they are new or unknown as robotic. Because this activity can be misinterpreted as human readership, data may be re-processed periodically to reflect an improved understanding of robotic activity. Because of these factors, readers should consider usage information illustrative but subject to change.

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts